Literature DB >> 31798212

Intraoperative Irreversible Electroporation in Locally Advanced Pancreatic Cancer: A Guide for the Interventional Radiologist.

Gregory T Frey1, Carlos A Padula1, John A Stauffer2, Beau B Toskich1.   

Abstract

Efforts to improve mortality associated with locally advanced pancreatic cancer (LAPC) have shown minimal gains despite advances in surgical technique, systemic treatments, and radiation therapy. Locoregional therapy with ablation has not been routinely adopted due to the high risk of complications associated with thermal destruction of the pancreas. Irreversible electroporation (IRE) is an emerging, nonthermal, ablative technology that has demonstrated the ability to generate controlled ablation of LAPC while preserving pancreatic parenchymal integrity. IRE may be performed percutaneously or via laparotomy and will commonly involve multidisciplinary treatment teams. This article will describe the technical aspects of how multidisciplinary IRE is performed during laparotomy at a single tertiary care institution. © Thieme Medical Publishers.

Entities:  

Keywords:  ablation; interventional radiology; irreversible electroporation; locally advanced pancreatic cancer; pancreas

Year:  2019        PMID: 31798212      PMCID: PMC6887528          DOI: 10.1055/s-0039-1697640

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  36 in total

Review 1.  Radiofrequency ablation for advanced ductal pancreatic carcinoma: is this approach beneficial for our patients? A systematic review.

Authors:  Raffaele Pezzilli; Carla Serra; Claudio Ricci; Riccardo Casadei; Francesco Monari; Marielda D'Ambra; Francesco Minni
Journal:  Pancreas       Date:  2011-01       Impact factor: 3.327

2.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

3.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

4.  Design of an irreversible electroporation system for clinical use.

Authors:  Claudio Bertacchini; Pier M Margotti; Enrico Bergamini; Andrea Lodi; Mattia Ronchetti; Ruggero Cadossi
Journal:  Technol Cancer Res Treat       Date:  2007-08

Review 5.  Stage III pancreatic cancer and the role of irreversible electroporation.

Authors:  Mohammad Al Efishat; Christopher L Wolfgang; Matthew J Weiss
Journal:  BMJ       Date:  2015-03-18

6.  Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.

Authors:  Rasmus Virenfeldt Flak; Mogens Tornby Stender; Thomas Mandøe Jensen; Kasper Lenni Andersen; Stine Dam Henriksen; Peter Brøndum Mortensen; Mogens Sall; Ole Thorlacius-Ussing
Journal:  Scand J Gastroenterol       Date:  2019-03-24       Impact factor: 2.423

7.  Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.

Authors:  Govindarajan Narayanan; Peter J Hosein; Isabelle C Beulaygue; Tatiana Froud; Hester J Scheffer; Shree R Venkat; Ana M Echenique; Elizabeth C Hevert; Alan S Livingstone; Caio M Rocha-Lima; Jaime R Merchan; Joseph U Levi; Jose M Yrizarry; Riccardo Lencioni
Journal:  J Vasc Interv Radiol       Date:  2016-12-16       Impact factor: 3.464

Review 8.  The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.

Authors:  Daniel Ansari; Stina Kristoffersson; Roland Andersson; Magnus Bergenfeldt
Journal:  Scand J Gastroenterol       Date:  2017-07-07       Impact factor: 2.423

Review 9.  Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.

Authors:  E Versteijne; J A Vogel; M G Besselink; O R C Busch; J W Wilmink; J G Daams; C H J van Eijck; B Groot Koerkamp; C R N Rasch; G van Tienhoven
Journal:  Br J Surg       Date:  2018-04-30       Impact factor: 6.939

10.  A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma.

Authors:  Li Yan; Yong-Liang Chen; Ming Su; Tian Liu; Kai Xu; Feng Liang; Wan-Qing Gu; Shi-Chun Lu
Journal:  Chin Med J (Engl)       Date:  2016-12-20       Impact factor: 2.628

View more
  2 in total

1.  A radiopaque polymer hydrogel as an irreversible electroporation compatible fiducial marker for pancreas stereotactic body radiotherapy.

Authors:  Eric M Anderson; Kenneth Park; Diana J Lu; Nicholas Nissen; Jun Gong; Andrew Hendifar; Alexandra Gangi; Simon Lo; Mitchell Kamrava; Katelyn M Atkins
Journal:  J Radiosurg SBRT       Date:  2020

Review 2.  Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies.

Authors:  Alaa Y Bazeed; Candace M Day; Sanjay Garg
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.